Navigation Links
Baxa Announces Colorado BioScience Association Sponsorship
Date:5/1/2008

a strong force in education and development for the industry.

Baxa Corporation is a Denver-based medical device manufacturer that employs more than 400 associates worldwide. The company provides in-kind and monetary support for a variety of local, national and international organizations as part of its community stewardship and social responsibility programs.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About Colorado BioScience Association (CBSA)

CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. Visit http://www.cobioscience.com.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Anesiva Announces First Quarter 2008 Financial Results Conference Call and Webcast
3. Anesiva Announces Expansion of Zingo Agreement in Europe
4. Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
5. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center
7. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
8. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
9. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
10. BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board
11. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Nov. 6 Helix BioPharma C...announced that John Docherty, president and chief ... Ford,s 6th annual Investor Summit on November 10,...City. Mr. Docherty will provide an overview of th...-DOS47 and Topical Interferon Alpha-2b. The slide...
(Date:11/6/2009)..., Nov. 6 ,, 3Q09 C...f Qutenza(TM) E.U. Marketing Authorization to Aste...s in commercial readiness activities Expanded man... Marketing; and Director, Commercial Operations A...and Audit Committee chairman , Upcoming 200...
(Date:11/6/2009)...Nov. 6 Intarcia Therapeutics, Inc.... (DUROS® continuous delivery of exenatide) pr...Ninth Annual Diabetes Technology Meeting in San Fr...cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Contin...50 Lowers Plasma Glucose, HbA1c and Reduces Weight...
(Date:11/5/2009)..., Nov. 5 GenVec, Inc. (N...ts for the third quarter ended September 30, 2009.... per share) for the three months ended September 3....08 per share) in the comparable quarter of 2008. ...ec,s net loss was $14.1 million ($0.15 per share),...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...Ariz., April 11 ImaRx Therapeutics,Inc. (Nasdaq: ...Staff,Deficiency Letter on April 11, 2008 indicati... the bid price of its common stock has closed,belo...to comply with the,minimum bid price requirement f... 4310(c)(4)., In accordance with Marketplace Rule...
...LE, S.C., April 11 Signalife, Inc.,(Amex: SGN ) ...nd the,company,s Chairman and Chief Executive Offi...st on April 14, 2008, at 10:00 a.m. EDT., Dr. Har...g the,company,s form 10-KSB and the Company is man...rovide direction on new contracts, pending orders,...
...O, California, April 11 , - Newly Established Org...AACR -, Ortho Biotech Oncology Research & Develop...ical Research & Development, L.L.C., will announce...s--Hdm2, c-Met, and HDAC,inhibitors --here at the ...08 Annual Meeting., "ORD is a new research and de...
Other Biology Technology:ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ's Minimum Bid Price Requirement 2Signalife Announces Webcast 2Signalife Announces Webcast 3Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 2Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 3Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 4Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 5
(Date:11/3/2009)...or more than 25 years, all attempts at culturing p... been unsuccessfuluntil now. For the first time, n... beaded (nucleated) and non-beaded cultured pearls...tists from Florida Atlantic University,s Harbor Br...n two years of research and experimentation, Drs. ...
(Date:11/3/2009)...lished in a recent issue of HortTechnology , scie... effects of covering orchard floors with reflectiv...t distribution, orchard temperature, and profitabi...y and Solarmate films installed 5 weeks before com...es. The research showed that the use of both films...
(Date:11/3/2009)...uch as 28 percent less likely to become pregnant a...rch that earned a Michigan State University profes...Luke, a researcher in the MSU College of Human Med...eproductive Biology, focused on data of nearly 50,..., Luke,s findings, which also can be applied to ...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Reflective film can boost profits for apple growers 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Veterans Give High Marks to VA Pharmacies 58710 1Veterans Give High Marks to VA Pharmacies 58710 2More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 1More than 5 000 Gallons of Bottled Water Now Available to Atlanta area Residents Coping with the Aftermath of Recent Flooding 58707 2Neurocrine Biosciences Amends Corporate Headquarters Lease 14319 1
...cientists have discovered how the zebrafish (Danio... findings add to the growing list of tasks carried...the arrangement of everything from nerve cells to ...e research focused on a particular zebrafish mutan...e of the four stripes running down its side is mis...
...leCop(R) In Use by More Than 100 Ohio Police Depar...al,Inc. (OTC Bulletin Board: BKYI), a leader in fi...ublic safety solutions today announced the,award o...Department for the,deployment of BIO-key,s MobileC...ps in patrol vehicles will provide,Youngstown,s po...
... A ghostly, mutant ratfish caught off Whidbey Isla...no fish ever seen by both the curator of the Unive...llection and a fish and wildlife biologist with mo... "Ratfish usually hang out in places with soft, m...ery sciences doctoral student who found the albino...
Other Biology News:Study shows how the zebrafish gets his stripe 2Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International 2Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International 3Rare albino ratfish has eerie, silvery sheen 2Rare albino ratfish has eerie, silvery sheen 3
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Rabbit Anti-Human WDR77 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: